#AlzeCure #AlzeCurePharma #pain #paintherapy #ACD440 #NeuPSIG2025 #neuropathicpain #peripheralneuropathicpain #TRPV1antagonist #heatinducedpain #strategicinlicensing #inlicensing #painrelief #painkillers #opioidcrisis #painprecisionmedicine #chronicneuropathicpain
pharmatimes.com/news/alzecur...
pharmatimes.com/news/alzecur...
AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025 - PharmaTimes
Clinical results from phase 2 study highlight analgesic effects in neuropathic pain patients
pharmatimes.com
September 2, 2025 at 8:28 AM